• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

January 19, 2020
Company Drug/Device Medical Condition Status
Alucent Biomedical Natural Vascular Scaffolding technology peripheral artery disease phase 1 trial enrolling up to 15 patients across five U.S. research sites
Clover Biopharmaceuticals SCB-313 malignant pleural effusions phase 1 trial dosing first patient in China
Tmunity CART-TnMUC1-01 TnMUC1-positive advanced cancers phase 1 trial dosing first patient
Cellectis UCART123 relapsed/refractory acute myeloid leukemia (AML) phase 1 trial dosing first patient
BioTheryX BTX-A51 relapsed/refractory AML phase 1 initiation of patient dosing
Innovation Pharmaceuticals Brilacidin ulcerative colitis phase 1 dosing of first cohort of 3 patients
Retrotope RT001 Friedreich’s ataxia phase 2/3 trial dosing of first patient
Zymeworks ZW25 locally advanced and/or metastatic HER2-positive, HR-positive breast cancer phase 2 trial initiated, enrolling up to 76 patients in the U.S. and Canada
Hutchison China MediTech surufatinib advanced solid tumors phase 2 trial initiated in China
Akero Therapeutics AKR-001 non-alcoholic steatohepatitis ongoing phase 2a trial expanded to include patients with compensated cirrhosis
Tolero Pharmaceuticals Alvocidib AML phase 2 trial first patient dosed
Tyme Technologies SM-88 (racemetyrosine) high-risk sarcomas phase 2 trial first patient dosed
Neuroptika NRO-1 dry eye disease phase 2 trial first patient enrolled of 120 patients
ContraFect exebacase Staph aureus bacteremia phase 3 trial first patient dosed, 350 patients
Akcea Therapeutics

Ionis Pharmaceuticals
AKCEA-TTR-LRx transthyretin-mediated amyloid cardiomyopathy phase 3 trial initiated
Abeona Therapeutics EB-101 recessive dystrophic epidermolysis bullosa phase 3 trial initiated, assessing up to 15 patients
Cerevel Therapeutics tavapadon Parkinson’s disease Phase 3 trial initiated, enrolling 1,200 patients
Novavax NanoFlu influenza in older adults Fast-Track designation granted by the FDA
Arena Pharmaceuticals APD418 decompensated heart failure Fast-Track designation granted by the FDA
Presage Biosciences CIVO Technology Platform cancer IND approved by the FDA
Lannett Company cocaine hydrochloride nasal solution local anesthetic NDA approved by the FDA
Novo Nordisk Ozempic (semaglutide) cardiovascular events in diabetes patients approved by the FDA for additional indication
Neurelis Valtoco (diazepam) nasal spray intermittent, stereotypic episodes of frequent seizure activity approved by the FDA

 

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing